13D Filing: Hudson Executive Capital and Corindus Vascular Robotics Inc (CVRS)

Page 2 of 8 – SEC Filing


  1

NAME OF
REPORTING PERSONS

Hudson Executive Capital LP

  2

CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP

(a)  ☐        (b)  ☐

  3

SEC USE ONLY

  4

SOURCE OF FUNDS

AF

  5

CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

  6

CITIZENSHIP OR PLACE OF
ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

  7

SOLE VOTING POWER

0

  8

SHARED VOTING POWER

26,861,154

  9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

26,861,154

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

26,861,154

12

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (11) EXCLUDES CERTAIN SHARES

13

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (11)

14.2%1

14

TYPE OF REPORTING PERSON

PN, IA

1 The percentage calculations herein are based upon 188,772,869 shares of common stock, par value $0.0001 per share outstanding as of March 15, 2018 as reported by the Issuer on March 16, 2018.

Follow Corindus Vascular Robotics Inc.